ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Ghia, Paolo, Pluta, Andrzej, Wach, Malgorzata, Lysak, Daniel, Kozak, Tomas, Simkovic, Martin, Kaplan, Polina, Kraychok, Iryna, Illes, Arpad, de la Serna, Javier, Dolan, Sean, Campbell, Phillip, MusuraJournal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.19.03355
Date:
May, 2020
File:
PDF, 939 KB
2020